Tofacitinib citrate 540737-29-9 Rheumatoid arthritis Anticancer
Kwishura:T / T, L / C.
Inkomoko y'ibicuruzwa:Ubushinwa
Icyambu cyo kohereza:Beijing / Shanghai / Hangzhou
Ubushobozi bwo gukora:100kg / ukwezi
Tegeka (MOQ):25kg
Igihe cyo kuyobora:Iminsi y'akazi
Imiterere y'ububiko:Ubitswe ahantu hakonje, humye, ubushyuhe bwicyumba.
Ibikoresho bipakira:ingoma
Ingano yububiko:25kg/ingoma
Amakuru yumutekano:Ntabwo ari ibintu biteje akaga
Intangiriro
Tofacitinib, ni imiti ikoreshwa mu kuvura rubagimpande ya rubagimpande, arthrite ya psoriatic, na colitis ulcerative.
Citrate ya Tofacitinib ikoreshwa mu kuvura abantu bakuru bafite rubagimpande ya rubagimpande ya rubagimpande zidafite ibisubizo bidahagije, cyangwa batihanganira methotrexate.
Citrate ya Tofacitinib yerekanwa mu kuvura indwara ya rubagimpande (RA) ikabije kandi ikabije ku bantu bakuze bitabiriye bihagije, cyangwa batihanganira imiti imwe cyangwa myinshi ihindura indwara imiti igabanya ubukana.
Ibisobanuro (mu nzu)
| Ingingo | Ibisobanuro |
| Kugaragara | Ifu yera cyangwa yera-ifu ya kristaline |
| Kumenyekanisha | IR, HPLC |
| Amazi | .5 1.5% |
| Ibintu bifitanye isano | TOFA 06 ≤0.15% |
| Tofacitinib trans isomer ≤0.15% | |
| Tofacitinib idafite umwuma ≤0.15% | |
| Buri mwanda utazwi ≤0,10% | |
| Impanuka zose: ≤1.0% | |
| Ibisigisigi bisigaye | Ethanol ≤5000ppm |
| Benzene ≤2ppm | |
| Toluene ≤890ppm | |
| Chlroroethane ≤1000ppm | |
| N, N-Dimethylformamide ≤800ppm | |
| Palladium ≤10ppm | |
| Dichloromethane ≤600ppm | |
| Ivu | ≤0.1% |
| Icyuma kiremereye | ≤10ppm |
| HPLC | 3S, 4S tofacitinib ≤0.15% |
| Suzuma (ku buryo budasanzwe) 98.0-102.0% |
